Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART

Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART

Autor Pessoa, Silvana D. Autor UNIFESP Google Scholar
Miyamoto, Maristela Autor UNIFESP Google Scholar
Ono, Erika Autor UNIFESP Google Scholar
Gouvêa, Aida de Fátima Thomé Barbosa Autor UNIFESP Google Scholar
Moraes-Pinto, Maria Isabel de Autor UNIFESP Google Scholar
Succi, Regina C. M. Autor UNIFESP Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo Humoral immune response to vaccine antigens is known to be reduced in perinatally HIV-infected children. Lymphocyte immunophenotyping, humoral immunity to hepatitis B after primary immunization and response to revaccination were evaluated in 40 HIV-infected adolescents on HAART and 23 healthy age-matched controls. Anti-HBs antibody levels >= 10 mIU/mL were found in 18/40 (40.5%) of the HIV-infected adolescents and 18/23 (78.3%) of the HIV-negative adolescents from Control group. Adolescents of HIV group with anti-HBs >= 10 mIU/mL presented a higher CD4+ T cell percentage, higher naive and central memory CD8+ T cell percentages and lower immune activation markers. After revaccination, 12/18 (66.7%) adolescents of HIV group responded. Those adolescents who did not respond to revaccination presented a lower CD4+ T cell percentage, higher immune activation markers and more frequently detectable HIV viral load. We concluded that lower immune activation, higher CD4+ T cell percentage and better control of HIV replication may be associated with hepatitis B vaccine response. (C) 2009 Elsevier B.V. All rights reserved.
Assunto Hepatitis B vaccine
HIV
CD38
Idioma Inglês
Financiador Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Número do financiamento FAPESP: 04/15934-0
Data 2010-02-10
Publicado em Vaccine. Oxford: Elsevier B.V., v. 28, n. 6, p. 1606-1612, 2010.
ISSN 0264-410X (Sherpa/Romeo, fator de impacto)
Editor Elsevier B.V.
Extensão 1606-1612
Fonte http://dx.doi.org/10.1016/j.vaccine.2009.11.045
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000275301900026
URI http://repositorio.unifesp.br/handle/11600/32266

Mostrar registro completo




Arquivos deste item

Arquivos Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item aparece na(s) seguinte(s) coleção(s)

Buscar DSpace


Navegar

Minha conta